Germline genetic testing is increasingly performed after a cancer diagnosis. The diffusion of
more extensive genetic testing for hereditary cancer syndromes has accelerated into …

Purpose Anecdotal reports suggest that the volume of services offered to individuals
concerned with hereditary cancer risk has increased substantially in recent years. As a …

The field of oncology has made great strides in the last decade. There have been
tremendous advancements in precision oncology and cutting-edge diagnostics to match the …

Cancer genetic testing is a revolutionary medical approach that involves the assessment of
genetic markers in asymptomatic individuals to predict their future susceptibility to cancer …

The American Society of Clinical Oncology (ASCO) has long affirmed that the recognition
and management of individuals with an inherited susceptibility to cancer are core elements …

As the leading organization representing cancer specialists involved in patient care and
clinical research, the American Society of Clinical Oncology (ASCO) reaffirms its …

Over recent years significant molecular advances have led to a better understanding of the
genetics of both syndromic and non-syndromic paediatric cancers. In addition many …

Germline genetic sequencing is now at the forefront of cancer treatment and preventative
medicine. Cascade genetic testing, or the testing of at-risk relatives, is extremely promising …

Advances in the application of genomic technologies in clinical care have the potential to
increase existing healthcare disparities. Studies have consistently shown that only a fraction …

Approximately 10% of all children with cancer are affected by a monogenic cancer
predisposition syndrome. This has important implications for both the child and her/his …